双鹭药业：董事拟减持公司不超0.0365%股份

Core Viewpoint - The company, Shuanglu Pharmaceutical, announced that its board member and secretary, Liang Shuqiao, plans to reduce her shareholding by up to 375,200 shares, which represents no more than 0.0365% of the company's total share capital, through centralized bidding transactions, with no reductions during the window period [1] Summary by Category - Company Announcement - Shuanglu Pharmaceutical disclosed that Liang Shuqiao intends to sell a maximum of 375,200 shares [1] - The planned reduction accounts for 0.0365% of the total share capital of the company [1] - The share reduction will be conducted via centralized bidding transactions [1] - There will be no share reduction during the designated window period [1]